Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HICARE: Erbitux and Radiotherapy in Head and Neck Cancer
NCT01553032Phase 4Completed
- Start
- Jun 2011
- Primary completion
- May 2017
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of cetuximab in head and neck squamous cell carcinoma (HNSCC). Started Jun 2011; status: completed.
02
Drugs
cetuximab
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT01553032.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01553032.